Lucira Health won't be the last COVID-19-focused firm to face bankruptcy, layoffs, or stock price declines, as "COVID cash" dries up, experts said.
In Brief This Week: Sophia Genetics, Sense Biodetection, Yourgene, Biodesix, DermTech, Chembio, More
News items for the week of Oct. 31, 2022.
As Abbott Stock Rises on EUA for Antigen Test, Competitors' Shares Take a Hit
While the market ditched shares of many other diagnostics firms, analysts said the reaction was overblown, particularly in the case of Quidel and molecular diagnostics players.
GenMark Diagnostics, Chembio Diagnostics Price Stock Offerings
GenMark said it intends to use the proceeds for general corporate purposes that may include an expansion of its menu and increasing its manufacturing capacity.
FIND Awards Grants for Development of HCV Dx Tests
Several companies will receive grants to develop hepatitis C molecular point-of-care and core antigen diagnostic assays.
Feb 19, 2016
Chembio Lands $550K Grant to Develop POC Zika Assay
Dec 14, 2012
Sep 14, 2012